ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinomaHailong Sheng, Chuanhui Cao, Hui Wang et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 225
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activationJingyuan Sun, Dehua Wu, Mengying Shen et al.|Journal of Experimental & Clinical Cancer Research|2020Cited by 97
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapyYan-Pei Zhang, Zhong‐Yi Dong, Yang-Si Li et al.|Cancer Cell|2025Cited by 30